Aventura at Creekside: Doctor Ignores Drug Warnings - PA
The consultant pharmacist flagged the issue during a November 2025 medication review, recommending consideration of a gradual dose reduction for the resident's Mirtazapine prescription. The antidepressant was prescribed at 15 milligrams for a patient diagnosed with bipolar disorder, a mental health condition causing significant mood and energy changes including episodes of depression and mania.
The resident, identified as Resident 4 in inspection records, had been admitted to the facility earlier in the year. Monthly medication reviews are required evaluations conducted by licensed pharmacists to identify potential concerns such as unnecessary medications, excessive doses, or harmful side effects.
But the attending physician never responded to the pharmacist's recommendation. No clinical rationale appeared in the resident's medical record explaining whether a dose reduction was attempted, deemed inappropriate, or even considered.
The facility's psychiatric nurse practitioner had documented that the resident previously failed a gradual dose reduction of Seroquel, an antipsychotic medication, and was considered stable on their current medication regimen. However, this note addressed a different medication entirely and provided no guidance about the Mirtazapine concerns raised by the pharmacist.
Federal inspectors found the clinical record contained no documentation from the attending physician addressing the identified irregularity. The physician provided no reason for continuing the current Mirtazapine dose without attempting the recommended gradual reduction.
A gradual dose reduction involves step-by-step lowering of medication to determine whether the drug remains necessary or whether symptoms can be managed with a lower dose or without the medication entirely. For psychiatric medications, this process helps identify the minimum effective dose and reduces potential side effects.
During their April 3, 2026 inspection, state officials interviewed the Assistant Director of Nursing at approximately 1:00 PM. The nursing administrator acknowledged the facility had experienced an ongoing problem obtaining documentation from the attending physician in response to consultant pharmacist recommendations.
This pattern suggests the communication breakdown extended beyond a single case. The nursing supervisor's admission indicates physicians regularly failed to document their clinical decision-making when pharmacists raised medication concerns.
The inspection report classified the violation as causing minimal harm or potential for actual harm, affecting few residents. However, the failure to document medical reasoning leaves patients vulnerable to inappropriate medication regimens without proper oversight.
Medication management becomes particularly complex for residents with bipolar disorder, where multiple psychiatric drugs often interact and require careful monitoring. Antidepressants like Mirtazapine can trigger manic episodes in bipolar patients if not properly balanced with mood stabilizers.
The consultant pharmacist system exists specifically to provide independent review of medication regimens in nursing homes, where residents often take multiple prescriptions with potential interactions. When attending physicians fail to engage with these recommendations, the safety net designed to protect vulnerable patients breaks down.
Pennsylvania regulations require facilities to ensure attending physicians act upon and document clinical rationale regarding consultant pharmacist identified medication irregularities. The state cited violations of pharmacy services, nursing services, and medical director requirements.
Aventura at Creekside operates at 45 North Scott Street in Carbondale, serving residents who depend on coordinated medical care from multiple providers. The facility's acknowledgment of ongoing physician documentation problems suggests systemic issues with medical oversight rather than isolated incidents.
The inspection revealed gaps in the fundamental communication between pharmacists identifying potential medication problems and physicians responsible for making clinical decisions about patient care. Without proper documentation, future providers cannot understand the reasoning behind medication choices, potentially compromising continuity of care.
Resident 4 remained on the flagged Mirtazapine regimen without documented medical justification for why a dose reduction was not attempted or considered inappropriate for their specific clinical situation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Aventura At Creekside from 2026-04-03 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 15, 2026 · Our methodology
AVENTURA AT CREEKSIDE in CARBONDALE, PA was cited for violations during a health inspection on April 3, 2026.
The resident, identified as Resident 4 in inspection records, had been admitted to the facility earlier in the year.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
Frequently Asked Questions
- What happened at AVENTURA AT CREEKSIDE?
- The resident, identified as Resident 4 in inspection records, had been admitted to the facility earlier in the year.
- How serious are these violations?
- Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
- What should families do?
- Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in CARBONDALE, PA, (5) Report any new concerns directly to state authorities.
- Where can I see the full inspection report?
- The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from AVENTURA AT CREEKSIDE or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 395984.
- Has this facility had violations before?
- To check AVENTURA AT CREEKSIDE's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.